Medications to Manage Sulfur Burps on Wegovy (Semaglutide 2.4 mg): First-Line and Beyond

Is any medicine established for sulfur burps on Wegovy?

No. The Wegovy label records eructation as an adverse reaction and does not recommend a medicine to treat it [1]. People ask about simethicone, bismuth subsalicylate, acid-reducing medicines and metoclopramide, but we found no study testing any of them specifically for sulfur burps in people taking Wegovy, and the evidence available does not show which, if any, helps.

What the Wegovy label records about burping and gas

The label's pooled safety data come from three placebo-controlled trials of Wegovy 2.4 mg weekly in adults with obesity or overweight, lasting up to 68 weeks (2,116 on Wegovy, 1,261 on placebo) [1]. Eructation occurred in 7% versus <1%, flatulence in 6% versus 4%, dyspepsia in 9% versus 3%, and any gastrointestinal reaction in 73% versus 47% [1]. Eructation is among the most common adverse reactions at 5% or more [1]. The label records burping but does not identify the gas responsible for its odor or explain why it occurs [1].

What the label says about other oral medicines

Wegovy delays gastric emptying, and the label says it may affect absorption of oral medicines, so increased clinical or laboratory monitoring should be considered for drugs with a narrow therapeutic index or that require clinical monitoring [1]. This applies to any medicine added to treat a Wegovy side effect only in the general sense the label states; it names no medicine for burping.

What the label flags as serious stomach symptoms

Severe gastrointestinal adverse reactions occurred in 4.1% of adults on Wegovy injection versus 0.9% on placebo, and the label states Wegovy is not recommended in patients with severe gastroparesis [1]. Postmarketing reports include ileus, intestinal obstruction and severe constipation with fecal impaction [1]. The label describes persistent or severe abdominal pain, sometimes radiating to the back, with or without nausea or vomiting, as a possible sign of acute pancreatitis, and says to discontinue Wegovy if pancreatitis is suspected [1].

Does a lower maintenance dose mean less burping?

For adult weight reduction, the Wegovy injection label lists 2.4 mg weekly as the recommended maintenance dose and 1.7 mg weekly as an alternative [1]. We found no data comparing burping at the two doses. The label increases doses in four-week steps during escalation [1].